FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joshua Korzenik

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Living Beings

Phenomena

Recurrence

Genes & Molecular Sequences

Metagenome

Anatomy

Co-author Network

Publications

TOP 3
Amit Desai; Joshua R Korzenik; Deanna D Nguyen; Vijay Yajnik; Zachary A Zator; Punyanganie de Silva; Ashwin N Ananthakrishnan
Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.
Ashwin N Ananthakrishnan; Joshua R Korzenik; Chin Hur
Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis.
Jessica E Ravikoff; Elisabeth B Cole; Joshua R Korzenik
Barriers to enrollment in inflammatory bowel disease randomized controlled trials: an investigation of patient perspectives.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joshua Korzenik (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Amit Desai; Joshua R Korzenik; Deanna D Nguyen; Vijay Yajnik; Zachary A Zator; Punyanganie de Silva; Ashwin N Ananthakrishnan
Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.
Inflammatory bowel diseases 2013;19(2):309-15.
2013: Ashwin N Ananthakrishnan; Joshua R Korzenik; Chin Hur
Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis.
Inflammatory bowel diseases 2013;19(1):37-44.
2012: Jessica E Ravikoff; Elisabeth B Cole; Joshua R Korzenik
Barriers to enrollment in inflammatory bowel disease randomized controlled trials: an investigation of patient perspectives.
Inflammatory bowel diseases 2012;18(11):2092-8.
2012: P S A de Silva; Joshua R Korzenik; D D Nguyen; J Sauk; V Yajnik; Ashwin N Ananthakrishnan
Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease.
Alimentary pharmacology & therapeutics 2012;36(5):459-66.
2012: P Juillerat; Ashwin N Ananthakrishnan; E F Cook; H Mogun; Sebastian Schneeweiss; Joshua R Korzenik
Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease.
Alimentary pharmacology & therapeutics 2012;36(3):239-47.
2012: Ashwin N Ananthakrishnan; Ying Bao; Charles S Fuchs; Edward L Giovannucci; Leslie M Higuchi; Hamed Khalili; Joshua R Korzenik; James M Richter; Andrew T Chan
Higher predicted vitamin D status is associated with reduced risk of Crohn's disease.
Gastroenterology 2012;142(3):482-9.
2012: Garret Cullen; Joshua R Korzenik; Caroline Bader; Bruce E Sands
Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.
Gut 2012;61(3):385-91.
2012: Ashwin N Ananthakrishnan; Chin Hur; Joshua R Korzenik
Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis.
Digestive diseases and sciences 2012;57(2):472-80.
2012: Xochitl C Morgan; Joshua A Reyes; Bruce E Sands; Samir A Shah; Scott B Snapper; Harry Sokol; Timothy L Tickle; Doyle V Ward; Ramnik J Xavier; Athos Bousvaros; Kathryn L Devaney; Dirk Gevers; Joshua R Korzenik; Neal LeLeiko; Curtis Huttenhower
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.
Genome biology 2012;13(9):R79.
2012: Eliseo Papa; Sarah P Preheim; David B Schauer; Christopher Smillie; Diana Tabbaa; Doyle V Ward; Sarah Weber; Ramnik J Xavier; Athos Bousvaros; Dawn Ciulla; Michael Docktor; Dirk Gevers; Georgia Giannoukos; Jay Ingram; Joshua R Korzenik; Elizabeth Alm
Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease.
PloS one 2012;7(6):e39242.
2011: A Tinsley; Joshua R Korzenik; E A Macklin; Bruce Sands
Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease.
Alimentary pharmacology & therapeutics 2011;34(11-12):1328-36.
2011: G Cullen; Adam S Cheifetz; D Kroshinsky; Joshua R Korzenik
Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.
Alimentary pharmacology & therapeutics 2011;34(11-12):1318-27.
2011: Ashwin N Ananthakrishnan; Chin Hur; Pascal Juillerat; Joshua R Korzenik
Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis.
The American journal of gastroenterology 2011;106(11):2009-17.
2011: Garrett C Zella; Elizabeth J Hait; Tiffany Glavan; Dirk Gevers; Doyle V Ward; Christopher L Kitts; Joshua R Korzenik
Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis.
Inflammatory bowel diseases 2011;17(5):1092-100.
2011: Sreedhar Subramanian; Vijay Yajnik; Bruce E Sands; Garret Cullen; Joshua R Korzenik
Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent.
Inflammatory bowel diseases 2011;17(1):99-104.
2011: Liliana Bordeianou; Sharon L Stein; Vanessa P Ho; Abdulmetin Dursun; Bruce E Sands; Joshua R Korzenik; Richard A Hodin
Immediate versus tailored prophylaxis to prevent symptomatic recurrences after surgery for ileocecal Crohn's disease?
Surgery 2011;149(1):72-8.
2010: Agnès Gardet; Yair Benita; Chun Li; Bruce E Sands; Isabel Ballester; Christine Stevens; Joshua R Korzenik; John D Rioux; Mark J Daly; Ramnik J Xavier; Daniel K Podolsky
LRRK2 is involved in the IFN-gamma response and host response to pathogens.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(9):5577-85.
2009: Anna Engelbrektson; Joshua R Korzenik; Arlyn Pittler; Mary E Sanders; Todd R Klaenhammer; Gregory Leyer; Christopher L Kitts
Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy.
Journal of medical microbiology 2009;58(Pt 5):663-70.
2009: Manuel Y Lam; Hang Lee; Renee Bright; Joshua R Korzenik; Bruce Sands
Validation of interactive voice response system administration of the Short Inflammatory Bowel Disease Questionnaire.
Inflammatory bowel diseases 2009;15(4):599-607.
2009: Elizabeth J Hait; Renée M Barendse; Janis H Arnold; Clarissa Valim; Bruce Sands; Joshua R Korzenik; Laurie N Fishman
Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists.
Journal of pediatric gastroenterology and nutrition 2009;48(1):61-5.
2008: Joshua R Korzenik
Flare factor: are there any triggering factors associated with onset of clinical symptoms or disease relapse?
Inflammatory bowel diseases 2008;14 Suppl 2():S150-1.
2007: Gilaad G Kaplan; C Hur; Joshua R Korzenik; Bruce Sands
Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysis.
Alimentary pharmacology & therapeutics 2007;26(11-12):1509-20.
2007: Gilaad G Kaplan; Bo V Pedersen; Roland E Andersson; Bruce Sands; Joshua R Korzenik; Morten Frisch
The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark.
Gut 2007;56(10):1387-92.
2006: Kumar S Bishnupuri; Qizhi Luo; Joshua R Korzenik; Jeffrey O Henderson; Courtney W Houchen; Shrikant Anant; Brian K Dieckgraefe
Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes.
Cancer biology & therapy 2006;5(12):1714-20.
2006: Jesús K Yamamoto-Furusho; Joshua R Korzenik
Crohn's disease: innate immunodeficiency?
World journal of gastroenterology : WJG 2006;12(42):6751-5.
2006: Brian K Dieckgraefe; Joshua R Korzenik; Shrikant Anant
Growth factors as treatment options for intestinal inflammation.
Annals of the New York Academy of Sciences 2006;1072():300-6.
2006: Joshua R Korzenik
Case closed? Diverticulitis: epidemiology and fiber.
Journal of clinical gastroenterology 2006;40 Suppl 3():S112-6.
2006: Anna L Engelbrektson; Joshua R Korzenik; Mary Ellen Sanders; Brian G Clement; Gregory Leyer; Todd R Klaenhammer; Christopher L Kitts
Analysis of treatment effects on the microbial ecology of the human intestine.
FEMS microbiology ecology 2006;57(2):239-50.
2006: Corey A Siegel; Chin Hur; Joshua R Korzenik; G Scott Gazelle; Bruce Sands
Risks and benefits of infliximab for the treatment of Crohn's disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(8):1017-24; quiz 976.
2006: Richard L Kradin; Kamran Badizadegan; Pavan Auluck; Joshua R Korzenik; Gregory Y Lauwers
Iatrogenic Trichuris suis infection in a patient with Crohn disease.
Archives of pathology & laboratory medicine 2006;130(5):718-20.
2006: Joshua R Korzenik; Daniel K Podolsky
Evolving knowledge and therapy of inflammatory bowel disease.
Nature reviews. Drug discovery 2006;5(3):197-209.
2006: Joshua R Korzenik; Daniel K Podolsky
Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(2):157-9.
2005: Joshua R Korzenik; Daniel C Chung; Subba Digumarthy; Kamran Badizadegan
Case records of the Massachusetts General Hospital. Case 33-2005. A 43-year-old man with lower gastrointestinal bleeding.
The New England journal of medicine 2005;353(17):1836-44.
2005: Steven J Lawrence; Joshua R Korzenik; Linda M Mundy
Probiotics for recurrent Clostridium difficile disease.
Journal of medical microbiology 2005;54(Pt 9):905-6.
2005: Joshua R Korzenik; Brian K Dieckgraefe; John Valentine; Diana F Hausman; Mark J Gilbert
Sargramostim for active Crohn's disease.
The New England journal of medicine 2005;352(21):2193-201.
2005: Joshua R Korzenik
Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators.
Journal of clinical gastroenterology 2005;39(4 Suppl 2):S59-65.
2005: Joshua R Korzenik; Brian K Dieckgraefe
An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease.
Alimentary pharmacology & therapeutics 2005;21(4):391-400.
2004: Joshua R Korzenik
Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab.
Gastroenterology clinics of North America 2004;33(2):285-301, ix.
2004: Bruce Sands; Frank H Anderson; Charles N Bernstein; William Y Chey; Brian G Feagan; Richard N Fedorak; Michael A Kamm; Joshua R Korzenik; Bret A Lashner; Jane E Onken; Daniel Rachmilewitz; Paul Rutgeerts; Gary Wild; Douglas C Wolf; Paul A Marsters; Suzanne Travers; Marion A Blank; Sander J H van Deventer
Infliximab maintenance therapy for fistulizing Crohn's disease.
The New England journal of medicine 2004;350(9):876-85.
2002: Brian K Dieckgraefe; Joshua R Korzenik
Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor.
Lancet 2002;360(9344):1478-80.
2002: Brian K Dieckgraefe; Joshua R Korzenik; Asif Husain; Lisa Dieruf
Association of glycogen storage disease 1b and Crohn disease: results of a North American survey.
European journal of pediatrics 2002;161 Suppl 1():S88-92.
2002: Aruna Krishnan; Joshua R Korzenik
Inflammatory bowel disease and environmental influences.
Gastroenterology clinics of North America 2002;31(1):21-39.
2000: Brian K Dieckgraefe; William F Stenson; Joshua R Korzenik; P E Swanson; Christina A Harrington
Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays.
Physiological genomics 2000;4(1):1-11.
2000: Joshua R Korzenik; Brian K Dieckgraefe
Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease.
Digestive diseases and sciences 2000;45(6):1121-9.
1998: A Husain; Joshua R Korzenik
Nutritional issues and therapy in inflammatory bowel disease.
Seminars in gastrointestinal disease 1998;9(1):21-30.